LINEAGE CELL THERAPEUTICS IN (LCTX) Institutional Ownership and Insiders Activity
LINEAGE CELL THERAPEUTICS IN (LCTX) is widely held by institutional investors, with 133 firms reporting positions valued at approximately $150.19M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Broadwood Capital Inc is the largest disclosed holder, reporting approximately $64.92M in LCTX holdings in its latest filing.
Institutional Holders
133
Total Reported Value
$150.19M
Largest Holder
Broadwood Capital Inc
Largest Position
$64.92M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
24
Funds Exiting Positions
13
Top Institutional Owners
View allInvestorReported Balance
- Broadwood Capital Inc$64.92M
- Blackrock, Inc.$17.27M
- Vanguard Capital Management Llc$11.86M
- Geode Capital Management, Llc$6.94M
- Raffles Associates Lp$6.81M
LCTX News
All news- Broadwood Capital Portfolio Concentration Analysis as of June 30, 2026
Aug 19, 2026 · valut.ai
Related LCTX Institutional Insights:
- LCTX 13F Institutional Holders
- LCTX Superinvestors
- LCTX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- LCTX Insider Trading & SEC Form 4 Activity
- LCTX Articles
- Top Institutional Investor Stock Rankings